Stock Updates

Is Novo Nordisk A/S(NYSE: NVO), a large market cap stock a smart buy?

With a market cap of has a large market cap size. Novo Nordisk A/S (NYSE: NVO) has been on the stock market since its IPO date on the 1/4/1982. Novo Nordisk A/S is in the Drug Manufacturers – Other industry and Healthcare sector. Average volume for Novo Nordisk A/S, is 1348.06, and so far today it has a volume of 550793. Performance year to date since the 1/4/1982 is -0.17%.

To help you determine whether Novo Nordisk A/S is undervalued the following values will help you decide. P/E is 28.47 and forward P/E is 23.25. PEG perhaps more useful shows that Novo Nordisk A/S has a value for PEG of 2.31. P/S ratio is 6.9 and the P/B ratio is 26.13. The P/Cash and P/Free cash flow is 85.77 and 40.64 respectively.

At the current price Novo Nordisk A/S is trading at, 56.93 (-0.07% today), Novo Nordisk A/S has a dividend yield of 1.69%, and this is covered by a payout ratio of 47.50%. Earnings per share (EPS) is 2, and this is looking to grow in the next year to 9.13% after growing 34.30% this past year. EPS growth quarter over quarter is -2.20%, and 8.00% for sales growth quarter over quarter.

The number of shares outstanding is 1984.68, and the number of shares float is 1356.68. The senior management bring insider ownership to 26.40%, and institutional ownership is at 10.20%. The float short is 0.17%, with the short ratio at a value of 1.75. Management has seen a return on assets of 40.40%, and also a return on investment of 85.00%.

The ability for Novo Nordisk A/S, to deal with debt, means it current ratio is 1.1, and quick ratio is 0.8. Long term debt/equity is 0 and total debt/equity is 0.01. In terms of margins, Novo Nordisk A/S has a gross margin of 84.90%, with its operating margin at 43.60%, and Novo Nordisk A/S has a profit margin of 31.30%.

The 52 week high is -3.98%, with 25.49% being its 52 week low. The 20 day simple moving average is 4.26% and the 200 day simple moving average is 5.13%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment